June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
UV-Independent p53 Mutations in Sebaceous Carcinoma of the Eyelid
Author Affiliations & Notes
  • Rehan Hussain
    Ophthalmology, Bascom Palmer Eye Institute, Miami, FL
  • Jared Matthews
    Ophthalmology, Bascom Palmer Eye Institute, Miami, FL
  • Sander Dubovy
    Ophthalmology, Bascom Palmer Eye Institute, Miami, FL
  • Gaofeng Wang
    Human Genetics, John P. Hussman Institute for Human Genomics, Miami, FL
  • Footnotes
    Commercial Relationships Rehan Hussain, None; Jared Matthews, None; Sander Dubovy, None; Gaofeng Wang, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 6212. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rehan Hussain, Jared Matthews, Sander Dubovy, Gaofeng Wang; UV-Independent p53 Mutations in Sebaceous Carcinoma of the Eyelid. Invest. Ophthalmol. Vis. Sci. 2013;54(15):6212.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

Sebaceous carcinoma (SC) is a potentially fatal neoplasm that has a tendency to arise in the eyelid. UV exposure and mutations of the p53 gene have been implicated in SC [1]. Kiyosaki et al reported a high frequency (67%) of p53 mutations in SC from Asian patients [2]. Most identified mutations of p53 in SC are point mutations, which are distinct from tandem mutations caused by UV exposure [1-3]. We analyzed p53 mutations in 14 cases to study the relationship between the frequency of p53 mutations and SC of the eyelid of Caucasians.

 
Methods
 

Sebaceous carcinoma of the eyelid resected from 14 Caucasian patients at Bascom Palmer Eye Institute from 1994 - 2010 were reviewed. An ophthalmic pathologist (SRD) performed histologic evaluation of each specimen. Carcinoma tissues were cut out by sterilized needles. Genomic DNA was extracted from paraffin-embedded tissues. PCR primers were chosen from a published study [4]. All 11 exons including flanking intronic regions were amplified by PCR and sequenced in both directions. Sequencing traces were analyzed. Sequence aberrations were confirmed by re-PCR and re-sequencing.

 
Results
 

Of the 14 SC samples, 7 were found to have p53 mutations (Table 1). Four specimens were found to have one p53 mutation. Two samples carried two mutations. One sample was identified with three missense mutations. We examined whether there is a possible relationship between the severity of p53 mutations and pathological features. We did not find any correlation between p53 mutations and pathologic features, tumor size, stage, recurrence or metastasis.

 
Conclusions
 

A high frequency of p53 mutations have been reported in SC of the eyelid from Asian patients [2]. Our data suggest that the frequency of p53 mutation is also high (50%) in SC from Caucasian patients. Mutations of p53 identified in previous studies are point mutations. In addition to 7 novel point mutations, a 9 bp deletion and a 6 bp insertion are also identified in our samples. No mutations are tandem mutations, suggesting that aberrant p53 is likely UV independent. There is no obvious correlation between severity of p53 mutations and pathological characterizations. The results suggest that UV independent mutations in p53 could be a pathogenic factor for SC of the eyelid.

 
 
Sebaceous carcinoma of the eyelid in a patient without p53 mutations. There is intraepithelial (pagetoid) spread in addition to the subepithelial carcinoma. (H&E, 40x)
 
Sebaceous carcinoma of the eyelid in a patient without p53 mutations. There is intraepithelial (pagetoid) spread in addition to the subepithelial carcinoma. (H&E, 40x)
 
Keywords: 744 tumors • 539 genetics • 526 eyelid  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×